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Abstract A lung cyst is defined as a round parenchymal
lucency or area of low attenuation with a thin wall. They
are not uncommon findings on high-resolution (HR)
thoracic computed tomography (CT) and when identified,
they require explanation. The differential diagnosis for
diseases characterised by lung cysts is broad ranging
from isolated chest disorders to rare multisystem dis-
eases. This article provides a practical approach for
evaluating lung cysts on HRCT, highlighting disorders in
which the HRCT findings can be diagnostic as well as
conditions where correlation with clinical history or
biopsy is required.
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Diagnostic approach
Introduction
With the exception of centrilobular emphysema, pulmonary
diseases characterised by cystic air spaces are uncommon or
rare conditions. However, unlike in other solid organs, the
lungs do not develop so-called simple cysts. Consequently,
when cysts are identified on computed tomography (CT),
an underlying reason for their existence should be sought.
The differential diagnosis for lung cysts is broad and
encompasses multisystem diseases in addition to cystic
diseases isolated to the chest (Table 1).
The purpose of this review is to provide a practical
approach to evaluating cysts when encountered on high-
resolution (HR) CT. The review initially deals with
disorders where HRCT features may be characteristic
and where the radiologist may confidently suggest a
diagnosis. This is followed by a review of scenarios in
which the appearances on CT are more non-specific, and
where integration with clinical and/or pathological
information is crucial. Disorders characterised by clus-
tered cyst formation, such as cystic bronchiectasis or
fibrotic lung disease associated with honeycombing, are
unlikely to ever be in the differential diagnosis of diffuse
cystic lung disease and therefore these are not discussed
in this review.
The pathological basis as well as the mechanisms
leading to cyst formation in the various cystic lung
diseases will also be briefly discussed. At the outset it
should be stressed that these mechanisms are very much
speculative in nature and include a ball-valve effect
causing bronchial dilatation, focal pulmonary necrosis
and retractile fibrosis.
Lung cysts on HRCT—how to proceed
Pulmonary cysts should first of all be differentiated from
pulmonary cavities because these two entities have very
different aetiologies. The definition of a lung cyst is a round
parenchymal lucency or area of low attenuation, usually
thin walled (less than 2-3 mm thick) and containing air, but
occasionally fluid or solid material (Fig. 1)[ 1]. A cavity, on
the other hand, is defined as a gas-filled space which
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nodule (Fig. 2)[ 1]. Additionally, in comparison with a lung
cyst, the wall of a cavity is usually relatively thick
(>4 mm). When assessing lung cysts on HRCT, the most
important feature that allows differentiation between dis-
eases is their distribution. Careful scrutiny of cyst shape
and size, as well as for the presence of any ancillary
findings, may help refine the differential diagnosis. Fre-
quently, a confident diagnosis cannot be made based on CT
alone and integration with clinical information is critical.
Ultimately in many cases, correlation with histopathology
is also required.
Scenario 1: multiple diffuse pulmonary
cysts—differentiating lymphangioleiomyomatosis
(LAM), Langerhans cell histiocytosis (LCH)
and centrilobular emphysema (CLE)
Pulmonary LCH
The Langerhans cell is a dendritic cell, found in many
organs. Proliferation and organ infiltration of these cells
results in either single or multi-organ disease [2]. Pulmo-
nary involvement develops most commonly in isolation and
occurs in young patients, between the ages of 20 and
40 years, almost all of whom are cigarette smokers. Patients
may be asymptomatic or present with dyspnoea. Less
frequently presenting complaints include chest pain and
fever [3].
The HRCT appearances of LCH vary according to the
chronicity of the disease. In the early stages, nodules
(which correspond with Langerhans cell granulomas) are
the predominant features, while cysts tend to develop later
[4]. It has been shown that cysts in LCH probably arise
because of focal dilatation of bronchi caused by destruction
of small airway bronchial walls due to Langerhans cell
lesions [5]. This may initially result in the nodules
appearing to cavitate and a differential diagnosis for
cavitating nodules may sometimes be incorrectly enter-
tained. However, the combination of nodules, cavitating
nodules and cysts in a smoker should allow a confident and
accurate diagnosis to be made on CT alone [6].
The cysts in LCH also have certain relatively unique
features which allow a confident distinction to be made
from LAM and emphysema. The cysts are typically
Fig. 1 HRCT image showing thin-walled cysts in the right lung
(arrow) in a patient with LAM
Fig. 2 HRCT shows a thick-walled cavity in the left lung adjacent to
the oblique fissure (arrow) in a patient with a pneumonia. Note the
thick wall and ragged edges to the cavity
Table 1 Diseases that may cause pulmonary cysts
Centrilobular emphysema
Lymphangioleiomyomatosis
Langerhans cell histiocytosis
Lymphoid interstitial pneumonia
Pulmonary metastases (squamous/adenocarcinoma)
Cystic fibrohistiocytic tumour of the lung
Subacute (± chronic) hypersensitivity pneumonitis
Barotrauma/ARDS
Pulmonary infection—pneumatocoeles
Desquamative interstitial pneumonia
Necrobiotic nodules (end stage)
Birt Hogg Dubé syndrome
Tracheal papillomatosis
Cystic mesenchymomas
Light-chain disease
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apices and relative sparing of the lung bases [7]. Another
helpful clue is observation of sparing of the medial tips of
the middle lobe and lingula (Fig. 3). The cysts can have
bizarre shapes and unequal sizes (Fig. 4). At this stage the
cysts probably reflect LC granuloma induced fibrosis rather
than bronchial dilatation.
LAM
LAM is a rare multi-organ disease characterised by
infiltration of immature-appearing smooth muscle cells in
the airways and along lymphatics in the chest and
abdomen. It occurs either as a pure pulmonary disease or
in association with tuberous sclerosis and is characterised
by pulmonary cysts [8]. It is a disease that is almost
exclusive to women of childbearing age and presents most
commonly with dyspnoea or recurrent pneumothoraces, and
occasionally haemoptysis [9].
In some patients, together with the correct clinical
picture, HRCT appearances may be regarded as pathogno-
monic. In other instances, where clinical or radiological
features are not typical, open or transbronchial lung biopsy
may be required. The typical HRCT pattern is one of
diffusely distributed multiple lung cysts, although the
number of cysts may vary. In patients with only a few
cysts, it is possible that interspaced HRCT can be ‘normal’
and the diagnosis made only after biopsy for the investiga-
tion of recurrent pneumothorax for example. The precise
aetiology of the cysts in not clear, but it may reflect focal
bronchiolar dilatation caused by a ball-valve effect due to
bronchial wall smooth muscle proliferation [10].
There are some key signs that help in differentiating
LAM from LCH. Perhaps the most useful differentiating
sign is the distribution of cysts. Unlike in LCH, cysts may
involve the juxtaphrenic recesses. On the other hand, there
is tendency for LAM cysts to spare the extreme apices
(Fig. 5)[ 11]. In contrast to LCH, the intervening lung
parenchyma is usually normal, although super-added
ground glass opacities have been reported [7]. The cysts
in LAM are typically thin walled and round in shape
(Fig. 6). Bizarre shaped cysts are less common in LAM
than LCH and tend to be seen in more end-stage disease
[12].
Fig. 3 HRCT demonstrates sparing of the medial segment of the
middle lobe and lingula in a patient with LCH (arrows)
Fig. 4 HRCT of a patient with LCH. Multiple cysts are present of
varying sizes and shapes (arrow)
Fig. 5 HRCT of a patient with LAM and right pneumothorax.
Coronal reformat demonstrates cystic involvement of the juxtraph-
renic recesses, but sparing of the extreme apices
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Areas of CLE are typically not surrounded by a wall and
the diagnosis of CLE on CT is usually not challenging.
However, CLE may appear as thin walled cysts and on
occasion can be very difficult to distinguish from LAM
[11]. Looking for certain CT features may help discriminate
between these conditions. CLE is characterised by the
presence of multiple rounded areas of low attenuation,
which have diameters of several millimetres and usually
have an upper lobe predominance [13]. The presence of a
central core vessel (centrilobular artery) in the low
attenuation cystic air space is classical of CLE (Fig. 7),
whereas the cysts in LAM are devoid of intracystic
structures [6]. The converse, however, does not hold true,
i.e. the absence of a core structure does not exclude CLE.
Scrutiny of the cyst wall may also help. As already
mentioned, CLE characteristically has no cyst wall,
whereas the cyst walls in LAM are typically 1-2 mm thick
[7]. However, this sign is not sufficiently robust to be relied
upon in isolation. Perceptible cyst walls in CLE are well
recognised (Fig. 7), while the cysts in LAM may on rare
occasions have no discernible wall [7]. Clearly, clinical
history is of paramount importance in cases where CT is
equivocal.
Scenario 2: scattered pulmonary cysts with ancillary CT
signs—differentiating lymphocytic interstitial
pneumonia (LIP), hypersensitivity pneumonitis (HP)
and desquamative interstitial pneumonia (DIP)
Cysts are a frequent finding in LIP and DIP and are
occasionally found in HP. In comparison with LAM or
LCH, cysts in these conditions are not as profuse and so the
distribution of disease does not help in refining the
differential diagnosis. Instead, careful scrutiny for ancillary
features, such as nodules and ground-glass opacities, is
required if a diagnosis is to be suggested on radiological
grounds. While nodules are a well recognised feature of
LCH, ground glass opacification is not typically associated
with either LCH or LAM.
LIP
LIP is an uncommon, benign, lymphoproliferative disorder
characterised pathologically by a diffuse lymphocytic
infiltrate. It is often associated with collagen vascular
disorders, in particular Sjogren’s syndrome, but is also
seen in patients with HIV infection [14]. Non-infection
associated LIP typically presents in women in the 5th
decade, with shortness of breath or cough [3]. The
Fig. 6 HRCT shows three cysts in the right lung of a patient with
LAM. Note the regular conformity of the cysts (arrow) with a thin
wall
Fig. 7 Coronal reformat CT thorax in a patient with CLE demon-
strates a cyst with a wall in the left lower lobe (arrow). More classical
CLE with a core centrilobular artery and a much less perceptible wall
is seen more superiorly (arrowhead)
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rare occasions to be complicated by pulmonary fibrosis or
to transform into lymphoma [15].
Ground-glass opacities and nodules are almost universal
features in LIP, with cysts seen in about two-thirds of
patients [16]. Interlobular sepal thickening and reticular
opacities have also been reported [7, 16]. The lung cysts are
usually small (less than 3 cm), thin walled and distributed
in a scattered, random distribution (Fig. 8), though much
larger cysts are also recognised [17].
Ultimately, most patients with suspected LIP on clinico-
radiological grounds will require lung biopsy to confirm the
diagnosis and in some cases to exclude low-grade lympho-
ma. At the same time, clinico-radiological integration with
histological findings is essential, because it can sometimes
be difficult for the pathologist to distinguish LIP from
hypersensitivity pneumonitis and NSIP [15].
Sub-acute HP
HP is a diffuse granulomatous inflammatory disease of the
lungs caused by exposure to a wide variety of agents
ranging from organic particles to chemotherapy agents.
Patients often present with gradually worsening dyspnoea,
but because the presence of a precipitating agent is not
always obvious from the clinical history, radiology has a
role to play in suggesting the diagnosis. The key histolog-
ical findings are bronchocentric lymphocytic infiltration
and poorly formed granulomas, but these abnormalities are
not always identified on lung or transbronchial biopsy,
adding sometimes to diagnostic uncertainty [18].
Cysts on HRCT are seen in approximately 10% of
patients with subacute HP and are usually few in number
and random in distribution (Fig. 9)[ 19]. Despite their low
frequency, the presence of cysts can be a helpful clue in
making a radiological diagnosis of HP, when identified in
conjunction with the more classical signs of the disease:
these are centrilobular ground glass nodules and a mosaic
attenuation pattern. Furthermore, all of these signs of sub-
acute HP can be seen in the more chronic fibrotic form of
hypersensitivity pneumonitis [19].
Contrasting imaging features and clinical history mean
that differentiating between HP and PCP (Pneumocystis
jirovecii) is never usually a diagnostic dilemma. PCP in
patients with AIDS commonly presents with diffuse ground
glass opacification, sepal thickening and occasional cysts,
but with no small airways disease [20].
DIP
DIP is an uncommon disorder characterised by macrophage
accumulation within the alveoli [21]. It causes dyspnoea or
cough and occurs almost exclusively in individuals exposed
to cigarette smoke. Consequently, knowledge of the smoking
history is mandatory before suggesting the diagnosis on
radiological grounds. On HRCT, diffuse ground glass
opacification is an expected finding in all patients [22]. By
itself, diffuse ground-glass opacification has a wide differ-
ential diagnosis, but the identification of small cysts admixed
within the ground glass opacity is a unique feature to DIP,
seen in about a third of patients (Fig. 10)[ 23, 24].
Scenario 3: isolated or scattered cysts with no ancillary
CT features
When HRCT shows just a few scattered cysts with no other
abnormal features, it can be difficult to determine whether
there is a true underlying cystic lung disease, or whether the
Fig. 8 HRCT shows thin walled cysts (arrow) and ground-glass
opacities (*) in a patient with LIP. The cysts have a random
distribution
Fig. 9 HRCT from a patient with subacute HP. Small cysts are
present (arrow) on a background of widespread ground glass opacity
and mosaic attenuation in the anterior segment of the left upper lobe
(*)
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Certain aspects of the clinical history may point towards a
diagnosis, but ultimately lung biopsy will be required if a
particular condition is suspected. For example, in a female
patient who presents with a pneumothorax, a few scattered
cysts may signify an early form of LAM (Fig. 11). If a
family history of recurrent pneumothoraces is elicited, a
diagnosis of Birt-Hogg-Dube syndrome may be suggested.
This is a very rare condition that is associated with
pneumothoraces, renal cell carcinomas and skin fibrofolli-
culomas [25]. Reports suggest that there is a lower zone
preponderance for cysts in Birt-Hogg-Dube (Fig. 12)[ 26].
Another rare cause of lung cysts is malignancy. While
cavitating malignant lung nodules are readily identified as
such and do not normally pose diagnostic difficulties, very
occasionally cystic metastases may present as exquisitely
thin-walled cysts. Such a diagnosis should be considered if
there is a history of primary squamous cell carcinoma,
adenocarcinoma or sarcoma malignancies elsewhere, and in
this scenario it is important not to dismiss new cystic
opacities as an incidental finding (Fig. 13)[ 27, 28].
Fig. 11 HRCTof a patient presenting with a pneumothorax (arrowhead).
The only parenchymal abnormality was the presence of a few small
cysts, such as the one in the posterior segment of the right upper lobe
(arrow). The patient was later diagnosed with LAM
Fig. 12 Coronal reformat CT thorax shows multiple thin-walled cysts
with a lower lobe predominance in a patient with Birt-Hogg-Dube. The
cysts have irregular shapes (arrow) and a right apical pneumothorax is
present (arrowhead). The patient had a family history of pneumothoraces
Fig. 10 HRCT showing widespread ground glass opacities and
several small cysts in a patient with a strong smoking history, who
was subsequently diagnosed with DIP
Fig. 13 Multiplecysticlesionsarepresentintheleftlung (arrow)w i t ha
small pneumothorax (arrowhead). The patient had a known history a
previous oropharyngeal squamous cell carcinoma and the lesions were
confirmed as cystic squamous cell carcinoma metastases
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A solitary or small number of apparently incidental lung cysts
may of course be a very early manifestation of any of the
disease processes described in Table 1.H o w e v e r ,i nt h e
absence of suspicious clinical features, further investigation
is unlikely to be instigated or necessary. Nevertheless, it is
important to try and explain their presence, as “simple” lung
cysts are not a recognised normal phenomenon. Possible
explanations include a focal area of CLE. Alternatively, a
single cyst could be the residual manifestation of previous
infection (i.e. a persistent pneumatocoele) [3]. In elderly
patients, lung cysts have also been reported in asymptomatic
non-smoking individuals, raising the possibility that they
may represent part of the aging process [29].
Conclusions
Lung cysts on HRCT are not an infrequent finding and
require explanation where possible. By scrutinising the
distribution and shape of pulmonary cysts as well as
looking for ancillary CT signs, in certain conditions HRCT
is diagnostic and no further investigation is required.
However, many cases will require correlation with clinical
history and biopsy for a definitive diagnosis.
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